Red Light Holland Corp. (CSE:TRIP)
0.0400
0.00 (0.00%)
Apr 28, 2026, 3:54 PM EST
Red Light Holland Revenue
Red Light Holland had revenue of 1.26M CAD in the quarter ending December 31, 2025, with 8.25% growth. This brings the company's revenue in the last twelve months to 4.17M, down -22.37% year-over-year. In the fiscal year ending March 31, 2025, Red Light Holland had annual revenue of 4.94M with 4.05% growth.
Revenue (ttm)
4.17M
Revenue Growth
-22.37%
P/S Ratio
4.08
Revenue / Employee
40.09K
Employees
104
Market Cap
17.03M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 4.94M | 192.40K | 4.05% |
| Mar 31, 2024 | 4.75M | 802.31K | 20.31% |
| Mar 31, 2023 | 3.95M | 1.62M | 69.84% |
| Mar 31, 2022 | 2.33M | 2.21M | 1,995.96% |
| Mar 31, 2021 | 110.96K | - | - |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Red White & Bloom Brands | 70.97M |
| 1CM Inc. | 75.01M |
| Voyageur Pharmaceuticals | 30.96K |
| Avicanna | 25.48M |
| Ayr Wellness | 650.97M |
| Crescita Therapeutics | 21.12M |
| Greenway Greenhouse Cannabis | 9.13M |
| MediPharm Labs | 45.12M |
Red Light Holland News
- 1 day ago - Red Light Holland Announces Filament Health Shareholder Approval of Acquisition - Newsfile Corp
- 4 days ago - Red Light Holland Showcases Growing Clinical Demand for Filament Health's PEX010 with New and Repeat University Shipments - Newsfile Corp
- 7 days ago - Kala Bio Celebrates Trump Executive Order as Game-Changer for Psychedelic Medicine - GlobeNewsWire
- 8 days ago - Red Light Holland Highlights U.S. FDA-Authorized Study Supporting Multi-Session Psilocybin Therapy using Filament Health's Patented PEX010 Botanical Drug Candidate - Newsfile Corp
- 21 days ago - Red Light Holland Reports Continued Expansion of Filament Health's PEX010 Clinical Network with New License Agreements and Research Shipments - Newsfile Corp
- 27 days ago - Red Light Holland to Support University of California San Francisco's Global Psychedelic Study Through Filament Health's Clinical Network - Newsfile Corp
- 5 weeks ago - Red Light Holland Announces Filament Health Obtains Interim Order for Proposed Arrangement - Newsfile Corp
- 5 weeks ago - Red Light Holland Engages Kala Bio's Researgency.AI Platform to Support Clinical Development of Filament's Patented PEX010 Botanical Psilocybin Drug Candidate - GlobeNewsWire